Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
trypanosomiasis/carbohydrate
Link salvestatakse lõikelauale
Leht 1 alates 22 tulemused
Carbohydrate metabolism in bovine trypanosomiasis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Carbohydrate metabolism in human trypanosomiasis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Trypanosomiasis: an approach to chemotherapy by the inhibition of carbohydrate catabolism.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
When the infected mammalian host of Trypanosoma brucei brucei is injected with a solution of the iron chelator salicyl hydroxamic acid and glycerol, the aerobic and anaerobic glucose catabolism of the parasite is blocked and the parasite is rapidly destroyed.
Carbohydrate immunity in American trypanosomiasis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Carbohydrate-Binding Non-Peptidic Pradimicins for the Treatment of Acute Sleeping Sickness in Murine Models.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Current treatments available for African sleeping sickness or human African trypanosomiasis (HAT) are limited, with poor efficacy and unacceptable safety profiles. Here, we report a new approach to address treatment of this disease based on the use of compounds that bind to parasite surface glycans
Carbohydrate-naphthalene diimide conjugates as potential antiparasitic drugs: Synthesis, evaluation and structure-activity studies.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The neglected tropical diseases Human African Trypanosomiasis and leishmaniasis are caused by infection with trypanosomatid parasites Trypanosoma brucei and Leishmania spp, respectively. The genomes of these organisms contain multiple putative G-quadruplex (G4) forming sequences which have recently
A plethora of targets, a paucity of drugs: progress towards the development of novel chemotherapies for human African trypanosomiasis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Human African trypanosomiasis is a major health problem in large regions of Africa. Current chemotherapeutic options are limited and far from ideal. A diverse range of drug targets has been identified and validated in trypanosomes. These include several organelles (glycosomes, acidocalcisomes,
Gambiense human african trypanosomiasis and immunological memory: effect on phenotypic lymphocyte profiles and humoral immunity.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
In mice, experimental infection with Trypanosoma brucei causes decreased bone marrow B-cell development, abolished splenic B-cell maturation and loss of antibody mediated protection including vaccine induced memory responses. Nothing is known about this phenomenon in human African trypanosomiasis
Hemolymphatic components in vectors of Trypanosoma cruzi: study in several species of the subfamily Triatominae (Hemiptera: Reduviidae).
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The members of the subfamily Triatominae (Hemiptera: Reduviidae) comprise a great number of species of medical importance in the transmission of the T. cruzi (American trypanosomiasis). The aim of this study was to contribute to the knowledge about the chemical composition in proteins, lipids,
Antigenic glycans in parasitic infections: implications for vaccines and diagnostics.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Infections by parasitic protozoans and helminths are a major world-wide health concern, but no vaccines exist to the major human parasitic diseases, such as malaria, African trypanosomiasis, amebiasis, leishmaniasis, schistosomiasis, and lymphatic filariasis. Recent studies on a number of parasites
Targeting the Pentose Phosphate Pathway: Characterization of a New 6PGL Inhibitor.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Human African trypanosomiasis, or sleeping sickness, is a lethal disease caused by the protozoan parasite Trypanosoma brucei. However, although many efforts have been made to understand the biochemistry of this parasite, drug development has led to treatments that are of limited efficiency and of
Trypanosome variable surface antigens: studies using two-dimensional gel electrophoresis and monoclonal antibodies.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Variable surface antigens of cloned populations of African trypanosomes were studied using 2-dimensional gel electrophoresis and monoclonal antibodies. Two-dimensional gel maps showed that the only major differences in protein profiles of the non-nuclear materials from different clones of
[Diabetes mellitus induced by pentamidine, without previous episodes of hypoglycemia, in patients with AIDS].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The onset of a pneumonia by P. carinii in AIDS patients have force scientist to look for others therapies against this parasite. It is more necessary when the first line treatment which is cotrimoxazol produced secondary effects or not therapeutic effects. Pentamidine which is an agent usually used
Trypanosoma cruzi cleaves galectin-3 N-terminal domain to suppress its innate microbicidal activity.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Galectin-3 is the best characterized member of galectins, an evolutionary conserved family of galactosides-binding proteins that play central roles in infection and immunity, regulating inflammation, cell migration, and cell apoptosis. Differentially expressed by cells and tissues with immune
Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
African trypanosomiasis is a deadly disease for which few chemotherapeutic options are available. The causative agents, Trypanosoma brucei rhodesiense and T. b. gambiense, utilize a non-cytochrome, alternative oxidase (AOX) for their cellular respiration. The absence of this enzyme in mammalian
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
